| 1 |
Screening the synergistic components of acetylcholinesterase inhibition from Phellodendron bark based on fingerprint-activity relationship modeling |
|
|
| Hong-Shan Zhou, Qi-Ming Luo, Xiao-Bing Lin, Chuan-Sheng Zhu, Ping Li, Wen Gao |
|
| World Journal of Traditional Chinese Medicine. 2023; 0(0): 0 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Identification of hepatoprotective traditional Chinese medicines based on the structure–activity relationship, molecular network, and machine learning techniques |
|
|
| Shuaibing He, Yanfeng Yi, Diandong Hou, Xuyan Fu, Juan Zhang, Xiaochen Ru, Jinlu Xie, Juan Wang |
|
| Frontiers in Pharmacology. 2022; 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Opportunities and hurdles to European market access for multi-herbal traditional Chinese medicine products: An analysis of EU regulations for combination herbal medicinal products |
|
|
| Liping Qu, Xiuli Li, Yin Xiong, Zhun Wang, Yuehua Zhou, Wenjun Zou, Jianyuan Tang, Mei Wang |
|
| Pharmacological Research. 2022; : 106528 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Market access for Chinese herbal medicinal products in Europe—A ten-year review of relevant products, policies, and challenges |
|
|
| Yin Xiong, Minghui Li, Pengyue Sun, Wen Liang, Ryan G. Hornbeck, Xiaoyan Che, Cheng Rao, Ye Zhao, Liqun Guo, Yan Huang, Hua Yang, Ping Li, Burt H. Kroes, Xiuming Cui, Gerhard Franz, Mei Wang |
|
| Phytomedicine. 2022; 103: 154237 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice |
|
|
| Liu Li,Li Yang,Feng Yang,Xin-lan Zhao,Shengjiang Xue,Fang-hua Gong |
|
| Journal of Inflammation Research. 2021; Volume 14: 1959 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment |
|
|
| Yan-Hong Shi,Yu-Feng Huang,Wang-Ying Wang,Li Yang,Hua Zhou,Zhen Sang |
|
| Pharmacological Research. 2020; 160: 105074 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Barriers and countermeasures in developing traditional Chinese medicine in Europe |
|
|
| Yunfang Liu,Zhiping Yang,Jing Cheng,Daiming Fan |
|
| Frontiers of Medicine. 2016; 10(3): 360 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs |
|
|
| Rolf Teschke,Dominique Larrey,Dieter Melchart,Gaby Danan |
|
| Medicines. 2016; 3(3): 18 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
